Acute ischemic stroke care in Germany – further progress from 2016 to 2019

Neurological Research and Practice - 2021
Daniel Richter1, Ralph Weber2, Jens Eyding2, Dirk Bartig1, Björn Misselwitz3, Armin J. Grau4, Werner Hacke5, Christos Krogias2
1Department of Neurology, St. Josef-Hospital Bochum, Ruhr University Bochum, Gudrunstr. 56, 44791, Bochum, Germany
2Medical Faculty, Ruhr University of Bochum, Bochum, Germany
3Institute of Quality Assurance Hesse, Eschborn, Germany
4Department of Neurology, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany
5Department of Neurology, University of Heidelberg, Heidelberg, Germany

Tóm tắt

Abstract Background Stroke Unit Care (SUC), intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are evidence-based treatment options for acute ischemic stroke (AIS). Using nationwide comprehensive administrative data from Germany, we recently reported nationwide development of AIS admissions, SUC rates, IVT rates and MT rates in Germany between 2010 and 2016. In this update paper, we analyze data on the further development of these data to 2019 after publication of time window extensions for recanalization therapies. Methods We considered all hospitalized cases with the main diagnosis of the ICD-10-GM code I63 (AIS) for the year 2019. We identified stroke therapies by using the corresponding Operating and Procedure Keys for IVT, MT and SUC out of the DRG statistics. Regional analyses are based on data from the 412 German administrative districts and cities. We compared the results with those from 2016. Results Number of hospitalized AIS patients showed a mild decrease in 2019 (n = 225,531) compared with 2016 (n = 227,687), with significant more AIS patients treated on a stroke unit in 2019 (n = 167,799; 74.4% vs. n = 164,270; 72.1%, p < 0.001). The rate of IVT further increased from 14.9% (n = 33,916) in 2016 to 16.3% (n = 36,745) in 2019 (p < 0.001). Similarly, the MT rate increased from 4.3% (n = 9795) in 2016 to 7.2% (n = 16,135) in 2019 (p < 0.001). There was still a high regional variability for MT (1.4 to 15.2%) according to the place of residence of the AIS patients. Conclusions In Germany, the rates of recanalization therapies in patients with AIS continued to increase from 2016 to 2019. Compared to IVT-rates and numbers, the respective data for MT procedures showed an even more pronounced increase.

Từ khóa


Tài liệu tham khảo

Eyding, J., Bartig, D., Weber, R., Katsanos, A. H., Weimar, C., Hacke, W., & Krogias, C. (2019). Inpatient TIA and stroke care in adult patients in Germany - retrospective analysis of nationwide administrative data sets of 2011 to 2017. Neurological Research Practice, 1, 39.

Weber, R., Eyding, J., Kitzrow, M., Bartig, D., Weimar, C., Hacke, W., & Krogias, C. (2019). Distribution and evolution of acute interventional ischemic stroke treatment in Germany from 2010 to 2016. Neurological Research Practice, 1, 4.

Berkhemer, O. A., Fransen, P. S., Beumer, D., MR CLEAN Investigators, et al. (2015). A randomized trial of intraarterial treatment for acute ischemic stroke. The New England Journal of Medicine, 372(1), 11–20.

Goyal, M., Demchuk, A. M., Menon, B. K., ESCAPE Trial Investigators, et al. (2015). Randomized assessment of rapid endovascular treatment of ischemic stroke. The New England Journal of Medicine, 372(11), 1019–1030.

Saver, J. L., Goyal, M., Bonafe, A., SWIFT PRIME Investigators, et al. (2015). Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. The New England Journal of Medicine, 372(24), 2285–2295.

Jovin, T. G., Chamorro, A., Cobo, E., REVASCAT Trial Investigators, et al. (2015). Thrombectomy within 8 hours after symptom onset in ischemic stroke. The New England Journal of Medicine, 372(24), 2296–2306.

Campbell, B. C., Mitchell, P. J., Kleinig, T. J., EXTEND-IA Investigators, et al. (2015). Endovascular therapy for ischemic stroke with perfusion-imaging selection. The New England Journal of Medicine, 372(11), 1009–1018.

Hacke, W., Kaste, M., Bluhmki, E., ECASS Investigators, et al. (2008). Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. New England Journal of Medicine, 359(13), 1317–1329.

Stroke Unit Trialists' Collaboration (2013). Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews, 9, CD000197.

Emberson, J., Lees, K. R., Lyden, P., Stroke Thrombolysis Trialists' Collaborative Group, et al. (2014). Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: A meta-analysis of individual patient data from randomised trials. Lancet, 384(9958), 1929–1935.

Goyal, M., Menon, B. K., van Zwam, W. H., HERMES collaborators, et al. (2016). Endovascular thrombectomy after large-vessel ischaemic stroke: A meta-analysis of individual patient data from five randomised trials. Lancet., 387(10029), 1723–1731.

Vanacker, P., Lambrou, D., Eskandari, A., Mosimann, P. J., Maghraoui, A., & Michel, P. (2016). Eligibility and predictors for acute revascularization procedures in a stroke center. Stroke, 47(7), 1844–1849.

Forlivesi, S., Bonetti, B., & Cappellari, M. (2018). Number of ischemic strokes potentially eligible for revascularization treatments in an Italian comprehensive stroke center: A modeling study. Journal of Thrombosis and Thrombolysis, 46(3), 427–430.

Chia, N. H., Leyden, J. M., Newbury, J., Jannes, J., & Kleinig, T. J. (2016). Determining the number of ischemic strokes potentially eligible for endovascular Thrombectomy: A population-based study. Stroke, 47(5), 1377–1380.

McMeekin, P., White, P., James, M. A., Price, C. I., Flynn, D., & Ford, G. A. (2017). Estimating the number of UK stroke patients eligible for endovascular thrombectomy. European Stroke Journal, 2(4), 319–326.

Albers, G. W., Marks, M. P., Kemp, S., DEFUSE 3 Investigators, et al. (2018). Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. The New England Journal of Medicine, 378(8), 708–718.

Nogueira, R. G., Jadhav, A. P., Haussen, D. C., DAWN Trial Investigators, et al. (2018). Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. The New England Journal of Medicine, 378(1), 11–21.

Thomalla, G., Simonsen, C. Z., Boutitie, F., WAKE-UP Investigators, et al. (2018). MRI-guided thrombolysis for stroke with unknown time of onset. The New England Journal of Medicine, 379(7), 611–622.

Ma, H., Campbell, B. C. V., Parsons, M. W., EXTEND Investigators, et al. (2019). Thrombolysis guided by perfusion imaging up to 9 hours after onset of stroke. The New England Journal of Medicine, 380(19), 1795–1803.

Ringleb, P., Bendszus, M., Bluhmki, E., ECASS-4 study group, et al. (2019). Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection. International Journal of Stroke, 14(5), 483–490.

Mokin, M., Ansari, S. A., McTaggart, R. A., Bulsara, K. R., Goyal, M., Chen, M., et al. (2019). Indications for thrombectomy in acute ischemic stroke from emergent large vessel occlusion (ELVO): Report of the SNIS standards and guidelines committee. Journal of NeuroInterventional Surgery, 11(3), 215–220.

Weber, R., Minnerup, J., Nordmeyer, H., Eyding, J., Krogias, C., Hadisurya, J., et al. (2019). Thrombectomy in posterior circulation stroke: Differences in procedures and outcome compared to anterior circulation stroke in the prospective multicentre REVASK registry. European Journal of Neurology, 26(2), 299–305.

Röther, J., Busse, O., Berlis, A., Dörfler, A., Groden, C., Hamann, G., & Nabavi, D. (2020). Interdisciplinary neurovascular networks: State of the art. Nervenarzt, 91(10), 902–907.

Richter, D., Eyding, J., Weber, R., Bartig, D., Grau, A., Hacke, W., & Krogias, C. (2020). Analysis of Nationwide stroke patient Care in Times of COVID-19 pandemic in Germany. Stroke. https://doi.org/10.1161/STROKEAHA.120.033160.

Richter, D., Krogias, C., Eyding, J., Bartig, D., Grau, A., & Weber, R. (2020). Comparison of stroke care parameters in acute ischemic stroke patients with and without concurrent Covid-19. A Nationwide analysis. Neurological Research Practice, 2, 48.

Stroke Unit Trialists' Collaboration (2002). Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews, 1, CD000197.

Leira, E. C., & Savitz, S. I. (2018). In the era of Thrombectomy, let us also protect the majority of patients with stroke who only require medical treatment! Stroke, 49(6), 1538–1540.

Aguiar de Sousa, D., von Martial, R., Abilleira, S., et al. (2019). Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries. European Stroke Journal, 4(1), 13–28.

Thomalla, G., Boutitie, F., Ma, H., Evaluation of unknown Onset Stroke thrombolysis trials (EOS) investigators, et al. (2020). Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: Systematic review and meta-analysis of individual patient data. Lancet, 396(10262), 1574–1584.

Rubin, M. N., & Barrett, K. M. (2015). What to do with wake-up stroke. The Neurohospitalist, 5(3), 161–172.

Krogias, C., Weber, R., Richter, D., Bartig, D., & Eyding, J. (2020). Nationwide treatment reality of patients with acute ischemic stroke in Germany : Update of the regionalized analysis on use of recanalization treatment procedures and stroke complex treatment. Nervenarzt, 91(10), 908–919.

Rikhtegar, R., Mosimann, P. J., Weber, R., Wallocha, M., Yamac, E., Mirza-Aghazadeh-Attari, M., & Chapot, R. (2020). Effectiveness of very low profile thrombectomy device in primary distal medium vessel occlusion, as rescue therapy after incomplete proximal recanalization or following iatrogenic thromboembolic events. Journal of NeuroIntervevntional Surgery. https://doi.org/10.1136/neurintsurg-2020-017035.

Thông tin
Thông tin xuất bản

Neurological Research and Practice

Thông tin tác giả